Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02881047 · ClinicalTrials.gov registry record · NA
Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02881047 is a NA study that was terminated before completion, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 8 participants.
The verdict
NCT02881047, a NA study, was terminated before completion, sponsored by Abramson Cancer Center at Penn Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Graft versus host disease (GVHD) is a common complication of allogeneic stem cell transplant.Chronic GVHD is characterized by skin thickening and tightening. Advanced sclerosis can lead to reduced range of motion and incapacitating joint contractures. Once present, there are few therapeutic options. We will treat sclerosis and limb contractures with an ablative fractional laser, a device FDA-approved for scar treatment. This approach has successfully treated contracturesdue to burn scars.
Interventions
- DEVICE CO2 Laser
- RADIATION Ultrasound
- DIAGNOSTIC_TEST Skin Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-11-11 |
| Est. Completion | 2016-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02881047
The ClinicalTrials.gov registry entry for NCT02881047 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CO2 Laser is the first listed.
NCT02881047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02881047 about?
NCT02881047 is a clinical study titled "Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures". Graft versus host disease (GVHD) is a common complication of allogeneic stem cell transplant.Chronic GVHD is characterized by skin thickening and tightening. Advanced sclerosis can lead to reduced range of motion and incapacitating joint contractures. Once present, there are few therapeutic options....
What is the current status of trial NCT02881047?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2013-11-11. Estimated completion is 2016-08-19.
What interventions are being tested in trial NCT02881047?
The interventions under investigation include: CO2 Laser (DEVICE), Ultrasound (RADIATION), Skin Biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02881047?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.